Literature DB >> 2794049

Rat renal epinephrine synthesis.

M G Ziegler1, B Kennedy, H Elayan.   

Abstract

Rats that underwent adrenal demedullation had a 93% decrease in plasma epinephrine (E) levels, but did not decrease their renal E. Even further treatment with 6-hydroxydopamine and reserpine failed to lower renal E levels. Similarly, urine E levels failed to decrease after adrenal demedullation and renal denervation. There is a renal E-synthesizing enzyme that differs from adrenal phenylethanolamine-N-methyltransferase (PNMT) in that it is only weakly inhibited by SKF 29661 and can synthesize epinine from dopamine, while adrenal PNMT does so poorly. When an adrenalectomized rat received intravenous [3H]methionine, its urine contained radioactivity that appeared to be [3H]E, with small amounts of [3H]epinine. However, after [3H]methionine was infused in the renal artery, the major product in urine appeared to be [3H]epinine, with a small amount of [3H]E. Adrenal demedullation induced renal E synthesis, but denervation returned the rate of renal E synthesis to control values. The combination of adrenal demedullation, 6-hydroxydopamine, and reserpine treatments increased renal E-forming activity to 350% of control. We conclude that appreciable portions of renal and urinary E are synthesized in the kidney by an enzyme distinct from PNMT. The enzyme is induced by some treatments that lower E and NE levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794049      PMCID: PMC329769          DOI: 10.1172/JCI114276

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Adrenaline excretion during resting conditions and after insulin in adrenalectomized human subjects.

Authors:  U von EULER; D IKKOS; R LUFT
Journal:  Acta Endocrinol (Copenh)       Date:  1961-11

2.  The physiological disposition of H3-epinephrine and its metabolite metanephrine.

Authors:  J AXELROD; H WEIL-MALHERBE; R TOMCHICK
Journal:  J Pharmacol Exp Ther       Date:  1959-12       Impact factor: 4.030

3.  THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN.

Authors:  H Chasis; H A Ranges; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1938-09       Impact factor: 14.808

4.  The effects of an inhibitor of phenylethanolamine N-methyltransferase upon stimulated adrenal catecholamine release and excretion in the rat.

Authors:  R G Pendleton; G Weiner; B Jenkins; G Gessner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

5.  Ontogeny of renal beta-adrenoceptor-mediated vasodilation in sheep: comparison between endogenous catecholamines.

Authors:  K T Nakamura; G P Matherne; P A Jose; B M Alden; J E Robillard
Journal:  Pediatr Res       Date:  1987-10       Impact factor: 3.756

Review 6.  Catecholamines and the kidney: receptors and renal function.

Authors:  P A Insel; M D Snavely
Journal:  Annu Rev Physiol       Date:  1981       Impact factor: 19.318

7.  The effect of epinephrine (USP), l-epinephrine, and l-norepinephrine on glomerular filtration rate, renal plasma flow, and the urinary excretion of sodium, potassium, and water in normal man.

Authors:  C M SMYTHE; J F NICKEL; S E BRADLEY
Journal:  J Clin Invest       Date:  1952-05       Impact factor: 14.808

8.  Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.

Authors:  A J Nichols; R R Ruffolo
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

9.  Evidence for the presence of functional beta-adrenoceptor along the proximal tubule of the rat kidney.

Authors:  W R Jacobs; Y L Chan
Journal:  Biochem Biophys Res Commun       Date:  1986-11-26       Impact factor: 3.575

10.  Epinephrine enhances neurogenic vasoconstriction in the rat perfused kidney.

Authors:  P Quinn; K R Borkowski; M G Collis
Journal:  Hypertension       Date:  1985 Jan-Feb       Impact factor: 10.190

View more
  5 in total

1.  Urinary Neurotransmitter Patterns Are Altered in Canine Epilepsy.

Authors:  Teresa Schmidt; Sebastian Meller; Steven R Talbot; Benjamin A Berk; Tsz H Law; Sarah L Hobbs; Nina Meyerhoff; Rowena M A Packer; Holger A Volk
Journal:  Front Vet Sci       Date:  2022-05-16

2.  Glucocorticoid induction of epinephrine synthesizing enzyme in rat skeletal muscle and insulin resistance.

Authors:  B Kennedy; H Elayan; M G Ziegler
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

3.  Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels.

Authors:  B Kennedy; T D Bigby; M G Ziegler
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model".

Authors:  Marty Hinz; Alvin Stein; Thomas Uncini
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-20

5.  Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice.

Authors:  Leticia Maria de Souza Cordeiro; Arwa Elsheikh; Nagavardhini Devisetty; Donald A Morgan; Steven N Ebert; Kamal Rahmouni; Kavaljit H Chhabra
Journal:  Diabetologia       Date:  2020-10-14       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.